128 related articles for article (PubMed ID: 36646059)
1. Clinical Value of Serum miR-106a in the Diagnosis and Prognosis of Human Papillomavirus-Positive Cervical Cancer.
Rao X; Jiang J; Wang Y; Ma X; Liu S
Intervirology; 2023; 66(1):54-62. PubMed ID: 36646059
[TBL] [Abstract][Full Text] [Related]
2. High Expression of Circular RNA-Mitochondrial tRNA Translation Optimization 1 Assists the Diagnosis of High-Risk Human Papillomavirus Infection in Cervical Cancer.
Cheng X; Shen C; Liao Z
J Low Genit Tract Dis; 2022 Jul; 26(3):212-218. PubMed ID: 35384929
[TBL] [Abstract][Full Text] [Related]
3. miR-106a Regulates Cell Proliferation and Autophagy by Targeting LKB1 in HPV-16-Associated Cervical Cancer.
Cui X; Wang X; Zhou X; Jia J; Chen H; Zhao W
Mol Cancer Res; 2020 Aug; 18(8):1129-1141. PubMed ID: 32345599
[TBL] [Abstract][Full Text] [Related]
4. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
[TBL] [Abstract][Full Text] [Related]
5. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.
Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G
DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269
[TBL] [Abstract][Full Text] [Related]
6. Serum miR-3142 could be Used as a Potential Biomarker to Screen Cervical Cancer Patients from Healthy Controls.
Luo Q; Wang H; Li J
Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969093
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of miR-3653 is Associated with HPV Infection and Serves as a Biomarker in Patients with Cervical Cancer.
Cui H; Zhang B; Ruan M; Fang C; Li N; Sun X; Qi J; Zuo R; Zhang S; Rong J
Int J Womens Health; 2022; 14():1037-1045. PubMed ID: 35966402
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between serum level of miRNA-106a expression with clinicopathological characteristics and prognosis of patients with renal cell carcinoma].
Yang Q; Liu J; Liang Y; Wang C; Han J; Zhu L; Yuan S; Sun Q; Zhang H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Jul; 38(7):652-655. PubMed ID: 34247370
[TBL] [Abstract][Full Text] [Related]
9. Down regulation of miR-143 is related with tumor size, lymph node metastasis and HPV16 infection in cervical squamous cancer.
Chen Y; Ma C; Zhang W; Chen Z; Ma L
Diagn Pathol; 2014 Apr; 9():88. PubMed ID: 24774218
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value of Vaginal Microecology, Serum miR-18a, and PD-L1 for Identifying HPV-Positive Cervical Cancer.
Zhang Y; Qiu S; Guo Y; Zhang J; Wu X; Hong G
Technol Cancer Res Treat; 2021; 20():1533033821995281. PubMed ID: 33632085
[TBL] [Abstract][Full Text] [Related]
11. Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer.
Cao X; Yao J; Jia M; Shen X; Zhang J; Ju S
J Ovarian Res; 2022 Feb; 15(1):20. PubMed ID: 35115025
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
Li D; Xu XX; Yan DD; Yuan SH; Lou HM
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
[No Abstract] [Full Text] [Related]
13. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.
Burger RA; Monk BJ; Kurosaki T; Anton-Culver H; Vasilev SA; Berman ML; Wilczynski SP
J Natl Cancer Inst; 1996 Oct; 88(19):1361-8. PubMed ID: 8827013
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus 16-positive uterine cervical squamous cell carcinoma with coinfection with human papillomavirus 34 has a lower incidence in lymph node metastasis than that without coinfection with human papillomavirus 34.
Michimata R; Watari H; Tomaru U; Sakuragi N; Ishizu A
Pathobiology; 2013; 80(5):259-64. PubMed ID: 23689419
[TBL] [Abstract][Full Text] [Related]
15. Expression of growth‑regulated oncogene‑1, hepatocyte growth factor, platelet‑derived growth factor‑AA and soluble E‑selectin and their association with high‑risk human papillomavirus infection in squamous cell carcinoma of the uterine cervix.
Zhang Y; Wu JZ; Yang YQ; Ma R; Zhang JY; Feng JF
Mol Med Rep; 2014 Aug; 10(2):1013-24. PubMed ID: 24889672
[TBL] [Abstract][Full Text] [Related]
16. Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma.
Chen J; Yao D; Li Y; Chen H; He C; Ding N; Lu Y; Ou T; Zhao S; Li L; Long F
Int J Mol Med; 2013 Sep; 32(3):557-67. PubMed ID: 23799609
[TBL] [Abstract][Full Text] [Related]
17. Survival‑related DLEU1 is associated with HPV infection status and serves as a biomarker in HPV‑infected cervical cancer.
Dong A; Xu B; Wang Z; Miao X
Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35014679
[TBL] [Abstract][Full Text] [Related]
18. Lymph node human papillomavirus DNA positivity in uterine cervical cancers and its relationship with prognostic factors.
Baser E; Can F; Unlukaplan M; Ayhan A
Int J Gynecol Cancer; 2011 Jan; 21(1):117-22. PubMed ID: 21330836
[TBL] [Abstract][Full Text] [Related]
19. Circulating and tissue miR-100 acts as a potential diagnostic biomarker for cervical cancer.
Yamanaka Z; Sasaki T; Yamanaka A; Kato K; Nishi H
Cancer Biomark; 2021; 32(4):551-558. PubMed ID: 34334379
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.
Jiang Y; Gu H; Zheng X; Pan B; Liu P; Zheng M
Pathol Oncol Res; 2021; 27():1609946. PubMed ID: 34992504
[No Abstract] [Full Text] [Related]
[Next] [New Search]